“EV Targeting MCF-7 Breast Cancer Cell Lines Inhibit Both mTOR and HIF-1A: Molecular Docking Study” (2021) Medico Legal Update, 21(1), pp. 1367–1373. doi:10.37506/mlu.v21i1.2511.